Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net Gain/(Loss)	$ (1,026,538)	$ (2,523,857)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	329	3,825
Warrants issued for services	402,100	434,836
Non-cash compensation	0	0
Change in fair value on derivative liability	246,260	1,287,971
Loss on extinguishment of debt	0	0
Gain on sale of asset	2,643	0
Impairment of goodwill	0	0
Changes in operating assets and liabilities
Accounts receivable	32,585	(70,311)
Inventory	91,523	(115,487)
Accrued interest receivable	0	0
Deposits	(16,890)	0
Accounts payable	76,799	(41,678)
Accounts payable - related party	0	0
Accrued liabilities	(52,330)	44,913
Accrued interest payable	16,621	27,450
Accrued interest payable - related party	(14,118)	10,162
Net Cash used in Operating Activities	(241,015)	(942,175)
Cash Flows from Investing Activities
Purchase of fixed assets	(7,987)	0
Cash received from sale of asset	0	0
Purchase of note receivable	0	0
Trademarks	0	(84,888)
Payments of note receivable	0	0
Cash flows provided by (used in) Investing Activities	(7,987)	(84,888)
Cash Flows from Financing Activities
Purchase of BergaMet	0	0
Purchase of UBN	0	0
Proceeds from issuance of common stock	(11,386)	225,000
Proceeds from issuance of convertible debt	445,826	858,000
Payments for repayment of convertible debt	(256,826)	0
Proceeds from issuance of noted payable	93,174	0
Proceeds from issuance of noted payable - related party	0	0
Payments for repayment of notes payable - related party	(170,000)	0
Net Cash provided by Financing Activities	100,788	1,083,000
Increase (decrease) in cash	(148,214)	55,937
Cash at beginning of period	222,098	59,201
Cash at end of period	$ 73,884	$ 115,138